MiraOne Comprehensive Blood Test Launched in Mumbai
L'essentiel
MiraOne, a comprehensive blood test, launched in Mumbai, provides a single report integrating blood markers, DNA analysis, and pharmacogenomics to offer personalized health insights, aiming to transform India's healthcare approach.
Résumé généré par IA
Pourquoi c'est important
Personalized medicine in India is at an inflection point, seeking more precise health solutions.
MiraOne, a comprehensive blood test, was launched on Saturday in Mumbai at the ImagiNXT conference. It integrates blood markers, DNA analysis, and pharmacogenomics into one report. Co-founded by Nickhil Jakatdar and Abhinav Kejriwal, MiraOne sequences 120 million DNA positions, offering deeper insights than standard tests. It aims to transform personalized medicine in India by providing actionable health data, moving beyond trial-and-error approaches in medication. Dr. Nikhil Phadke attended the launch.
The test highlights the genetic basis of health issues and pharmacogenomic responses to medications, ensuring more effective treatments. For example, a patient with elevated homocysteine might not benefit from standard folic acid if their genes cannot convert it, illustrating the need for genetic insights.
Jakatdar emphasized that MiraOne’s innovation lies in integrating three layers of health data into one report, facilitating precision medicine. The launch comes as India’s healthcare sector seeks more personalized approaches, indicating a potential shift towards data-driven health solutions.
À surveiller
Perspective IA — des possibilités, pas des certitudes
Increased adoption of MiraOne in Indian healthcare
Probable · En quelques mois
Questions ouvertes
- Cost and accessibility of MiraOne for the general population
